Tower Research Capital LLC (TRC) - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 45 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,641
+2.7%
6,760
+37.9%
0.00%
Q2 2023$12,304
+34077.8%
4,902
-76.5%
0.00%
-100.0%
Q1 2023$36
-68.7%
20,874
-22.9%
0.00%
-80.0%
Q4 2022$115
-99.2%
27,080
+137.7%
0.01%
Q3 2022$14,000
+55.6%
11,391
+21.7%
0.00%
Q2 2022$9,000
-10.0%
9,363
+124.2%
0.00%
Q1 2022$10,000
-9.1%
4,176
+2.3%
0.00%
Q4 2021$11,000
-8.3%
4,081
+73.0%
0.00%
Q3 2021$12,000
-53.8%
2,359
-31.3%
0.00%
-100.0%
Q2 2021$26,000
-7.1%
3,436
-28.7%
0.00%
Q1 2021$28,000
+55.6%
4,817
+27.3%
0.00%
-100.0%
Q4 2020$18,0003,7830.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders